BENGALURU: Indian pharmaceutical company Strides Pharma Science LtdNSE 1.46 % said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.
The US Food and Drug Administration (USFDA) has recently cleared the manufacturing facilities of four Indian pharmaceutical companies, The Economic Times reported.
Strides Pharma's Generic Triamcinolone Acetonide Receives Approval in US
Strides Pharma Science Limited’s step-down wholly-owned subsidiary Strides Pharma Global Limited, Singapore, has received the approval for potassium chloride extended-release tablets from the United States Food & Drug Administration (US FDA).